Influenza hemagglutinin and neuraminidase membrane glycoproteins
about
New world bats harbor diverse influenza A virusesViruses and sialic acids: rules of engagementMechanisms of hemagglutinin targeted influenza virus neutralizationA new in vitro hemagglutinin inhibitor screening system based on a single-vesicle fusion assay.A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutininsStructures of Merkel Cell Polyomavirus VP1 Complexes Define a Sialic Acid Binding Site Required for InfectionInsights into Avian Influenza Virus Pathogenicity: the Hemagglutinin Precursor HA0 of Subtype H16 Has an Alpha-Helix Structure in Its Cleavage Site with Inefficient HA1/HA2 CleavageInfluenza Virus Neuraminidases with Reduced Enzymatic Activity That Avidly Bind Sialic Acid ReceptorsStructural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA InhibitionHemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activitiesMolecular Basis of the Receptor Binding Specificity Switch of the Hemagglutinins from both the 1918 and 2009 Pandemic Influenza A Viruses by a D225G SubstitutionStructure and Receptor Binding Specificity of Hemagglutinin H13 from Avian Influenza A Virus H13N6A Structure-Guided Mutation in the Major Capsid Protein Retargets BK PolyomavirusStructures of B-Lymphotropic Polyomavirus VP1 in Complex with Oligosaccharide LigandsThe roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virusInsight into Highly Conserved H1 Subtype-Specific Epitopes in Influenza Virus HemagglutininAn airborne transmissible avian influenza H5 hemagglutinin seen at the atomic levelStructure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesChemoenzymatic site-specific labeling of influenza glycoproteins as a tool to observe virus budding in real timeInhibition of influenza H7 hemagglutinin-mediated entryResistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivirFunctional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice techniquePolygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expressionIdentification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput ScreeningInvestigation of the binding and cleavage characteristics of N1 neuraminidases from avian, seasonal, and pandemic influenza viruses using saturation transfer difference nuclear magnetic resonance.Surface modifications of influenza proteins upon virus inactivation by β-propiolactoneAn NA-deficient 2009 pandemic H1N1 influenza virus mutant can efficiently replicate in cultured cells.Interface dynamics explain assembly dependency of influenza neuraminidase catalytic activity.H7N9: A killer in the making or a false alarm?Mutagenesis studies of the H5 influenza hemagglutinin stem loop region.H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccination.Replication and transmission of mammalian-adapted H9 subtype influenza virus in pigs and quailCompetitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).Assessment of Anti-Influenza Activity and Hemagglutination Inhibition of Plumbago indica and Allium sativum ExtractsInfluenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1.Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 HemagglutininsConsensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.
P2860
Q21090482-4091912E-F4BE-4F58-BC63-19B9803F10BFQ26852325-84E17361-7F0D-4FD9-A3B7-07E35786317BQ27302234-4B7C348D-3078-41A6-9576-B43F2EC83691Q27321534-C2C46FEF-0413-4184-B5EC-0F6411830767Q27671165-9CEFED18-776C-4A73-809A-5B13E8358130Q27671637-A56F4DFC-6510-4EF5-B20E-40A28427EF06Q27673446-E1FF7BEF-98BD-4C55-A455-6ED9542EA17AQ27673691-32B37FB7-DD90-49CA-A00E-805013E2BAF4Q27675230-7F1F2DC9-29B3-438B-BA7D-B07D1B8143FDQ27675808-8E4D8B22-F273-49CB-BD13-FBB9AE62717BQ27676907-826D3654-A549-4C86-A11C-A96C1890E9C7Q27678588-FB397BF1-0E8F-4492-AE76-DCCAC8B01F85Q27680381-7ECB5CAD-AB0C-4A76-B22E-3AD0B755015DQ27680553-851D7271-49A0-4094-89B2-C8E8CE2ED879Q27681622-2E7C301B-E917-4195-8423-413A7FF1101AQ27681955-88473CE8-C965-47B0-9E7E-3B9E20C73622Q27684542-E2EEA903-A85D-441B-85A7-3DEB140496FAQ28396120-1F0AE667-6B03-4F5C-97C6-2BD0A7086176Q28481621-D18C1CE6-31DB-4306-88AB-04B67ED77E04Q28534616-9FE89396-CF0B-4C3F-B1EA-55EAEE38C4C3Q28535274-9EDD9C89-9F58-4191-AA90-0B9BAE2EF328Q28535298-A4C99C0C-FA84-4F19-9350-B2C901722F84Q28543242-BFD07148-9602-477B-AE08-7AAACCB60E68Q28830304-09A22C5D-3D20-458E-9688-14A6DC7ED455Q30354445-64027500-3ABE-47E3-A453-B272F81FE0D7Q30354494-AE0EB664-32C5-454D-AC7F-B1BBD9BE5B98Q30354739-BA56C3CE-B596-4C5B-885A-4162682A9050Q30356070-2111F792-0304-42FC-97DC-882A75AF047FQ30363225-548C56B6-596E-4C2C-B9C2-CB6B20383068Q30363789-94277FD3-0A0C-48D6-B4A2-02AA9AE428DBQ30371297-096BCA18-DF57-456F-B8F1-A84DA4649DEFQ30374791-E2F5F545-0DD6-43D9-A722-71588086C279Q30375314-6937CF8F-69A0-42B7-89E7-6A0F6738819DQ30386328-85E59478-3CAE-4F95-A023-E4B07140CD43Q30387167-EF34EABF-A794-49D8-9519-6FD1D9B13107Q30392359-D021059E-8DB0-4313-A628-A6C329DFF951Q30392944-7F7D7DB1-E11D-4B04-8974-D63BBEDA8D02Q30398228-34FC28D7-61DE-4B58-8AF8-85D6CFD11159Q30401009-691ADDB9-B9AA-4E13-A727-0E813721872DQ30403507-53A484E2-9575-4F3D-9630-907333AD78D3
P2860
Influenza hemagglutinin and neuraminidase membrane glycoproteins
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@ast
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@en
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@nl
type
label
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@ast
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@en
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@nl
prefLabel
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@ast
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@en
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@nl
P2860
P921
P356
P1476
Influenza hemagglutinin and neuraminidase membrane glycoproteins
@en
P2093
John J Skehel
Steven J Gamblin
P2860
P304
28403-28409
P356
10.1074/JBC.R110.129809
P407
P577
2010-06-10T00:00:00Z
2010-09-10T00:00:00Z